Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




New AI-Powered System Aims to Streamline Laboratory and Manufacturing Workflows

By LabMedica International staff writers
Posted on 21 Oct 2026

Scientific laboratories supporting drug development, biotechnology, and materials research increasingly rely on coordinated digital workflows to move data, samples, and activities across teams. More...

Fragmented systems and manual handoffs can slow progress, especially as work moves from research and development to manufacturing. A new system now connects and orchestrates scientific workflows from discovery through manufacturing in a single digital environment.

Revvity, Inc. (Waltham, MA, USA) has launched Signals LabGistics, an AI-first scientific workflow orchestration solution from its Revvity Signals Software business. The solution is designed to connect and coordinate processes, workflows, and tasks from discovery to manufacturing. It is intended for organizations working across pharmaceutical, biotechnology, specialty chemical, and materials science environments.

Signals LabGistics uses AI-powered workflow design to translate natural-language descriptions and standard operating procedures into coordinated scientific workflows. The system provides an orchestration layer that helps connect teams, systems, and processes so workflows can be executed more consistently. By linking real-time data and insights in a single digital environment, the solution is designed to support contextualized decision-making and continuous improvement of scientific processes.

The solution operates within the broader Revvity Signals Software ecosystem and is designed to work with existing laboratory and manufacturing platforms. It is also intended to extend to adjacent systems over time. Multi-tier execution and real-time monitoring capabilities are intended to improve information, sample, and activity flow across independent teams, while helping scientists and managers monitor workflow status, identify emerging bottlenecks, and respond before delays affect broader development timelines.

Signals LabGistics also includes flexible compliance and quality capabilities tailored to industry requirements. These capabilities can support pharmaceutical and biotechnology organizations that need to maintain GxP compliance across connected environments, as well as specialty chemicals and materials science companies seeking to minimize additional regulatory overhead. Signals LabGistics is expected to be available in the United States, Canada, Europe, and Japan in December 2026.

“Scientific innovation is increasingly dependent on the ability to coordinate work across people, systems and stages of development. Our Signals LabGistics offering brings those moving parts together and helps organizations move promising therapies and new products forward with greater speed, consistency and confidence,” said Kevin Willoe, president of Revvity Signals Software.

Related Links
Revvity


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Gold Member
Automatic Hematology Analyzer
CF9600
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: New evidence now questions whether a single stool-test cutoff should be applied uniformly across all age groups.(Photo courtesy of Paul Maguire - Adobe Stock)

Study Questions Uniform Stool-Test Cutoff Across Age Groups

Colorectal cancer remains a major clinical challenge, ranking as the fourth most common cancer and the second-leading cause of cancer death in the U.K. Early-onset colorectal cancer, defined as diagnosis... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image

Labcorp Partners With Grupo Fleury to Expand Clinical Trial Operations in Brazil

Multinational clinical trials require laboratory partners that combine global expertise with local operational capabilities. Brazil is an important clinical research destination, supported by its diverse... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.